首页> 外文期刊>Pediatric nephrology: journal of the International Pediatric Nephrology Association >Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schonlein purpura
【24h】

Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schonlein purpura

机译:膜攻击复杂沉积在IgA肾病和Henoch-Schonlein Purpura儿童中的临床相关性

获取原文
获取原文并翻译 | 示例
           

摘要

Background IgA nephropathy (IgAN) and Henoch-Schonlein purpura are common glomerular disorders in children sharing the same histopathologic pattern of IgA deposits within the mesangium, even if their physiopathology may be different. Repeated exposure to pathogens induces the production of abnormal IgA1. The immune complex deposition in the renal mesangium in IgAN or potentially in small vessels in Henoch-Schonlein purpura induces complement activation via the alternative and lectin pathways. Recent studies suggest that levels of membrane attack complex (MAC) in the urine might be a useful indicator of renal injury. Because of the emerging availability of therapies that selectively block complement activation, the aim of the present study is to investigate whether MAC immunostaining might be a useful marker of IgA-mediated renal injury. Methods We conducted immunohistochemistry analysis of the MAC on renal biopsies from 67 pediatric patients with IgAN and Henoch-Schonlein purpura. We classified their renal biopsies according to the Oxford classification, retrieved symptoms, biological parameters, treatment, and follow-up. Results We found MAC expression was significantly related to impaired renal function and patients whose clinical course required therapy. MAC deposits tend to be more abundant in patients with decreased glomerular filtration rate (p = 0.02), patients with proteinuria > 0.750 g/day/1.73 m(2), and with nephrotic syndrome. No correlation with histological alterations was observed. Conclusions We conclude that MAC deposition could be a useful additional indicator of renal injury in patients with IgAN and Henoch-Schonlein purpura, independent of other indicators.
机译:背景技术IgA肾病(Igan)和Henoch-Schonlein Purpura是儿童常见的肾小球疾病,即使它们的生理疗学可能不同,儿童在儿童中共用相同的IgA沉积物组织病理学模式。对病原体反复接触诱导IgA1的产生产生。 IgAn中肾mesangium的免疫复合物沉积或在Henoch-Schonlein Purpura的小血管中通过替代和凝集素途径诱导补体激活。最近的研究表明,尿液中膜攻击复合物(MAC)的水平可能是肾损伤的有用指标。由于选择性地阻断补体激活的疗法的新出现的可用性,目前研究的目的是研究MAC免疫染色是否可能是IGA介导的肾损伤的有用标志物。方法对67名儿科患者肾活检对67名儿科患者的免疫组化分析进行了免疫组织化学分析。我们根据牛津分类,检索症状,生物参数,治疗和随访归类肾活检。结果我们发现MAM表达与肾功能受损的肾功能和临床过程治疗的患者显着相关。肾小球过滤速率下降(P = 0.02),蛋白尿患者往往更丰富,蛋白尿患者> 0.750克/日/ 1.73米(2),以及肾病综合征。没有观察到与组织学改变的相关性。结论我们得出结论,MAC沉积可能是Igan和Henoch-Schonlein Purpura患者肾损伤的有用额外指标,与其他指标无关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号